Trial Analysis Characterizes SCLC Disease Progression ...Middle East

Medscape - News
Trial Analysis Characterizes SCLC Disease Progression
An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any metastases with durvalumab vs placebo. Medscape Medical News

Hence then, the article about trial analysis characterizes sclc disease progression was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial Analysis Characterizes SCLC Disease Progression )

Apple Storegoogle play

Last updated :

Also on site :